COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20200927048849N3


Column Value
Trial registration number IRCT20200927048849N3
Full text link
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Rasoul Roknizadeh

Contact
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

research.deputy@dean.ui.ac.ir

Registration date
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-03-17

Recruitment status
Last imported at : May 20, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Infected patients of COVID-19 based on positive Polymerase Chain Reaction test Lack of hospitalization indication based on country protocol O2 Saturation more than 93% on the first visit Respiratory rate more than 24 on the first visit Age more than 18 years old Filling and signing of consent form A maximum of 10 days have elapsed since the onset of disease symptoms

Exclusion criteria
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Patients with immunodeficiency based on biography Lactose intolerance based on biography Uncontrollable vomiting Using antiviral drugs Pregnancy Failure to fill out the consent form Receiving immunosuppressive drugs

Number of arms
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Isfahan university

Inclusion age min
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

100

Countries
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Mild disease at enrollment

Severity scale
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

1: Mild disease at enrollment

Total sample size
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

600

primary outcome
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Need of Hospitalization during the next 14 days Need to go to the emergency room during 14 days No fever and appearance of it No cough and appearance of it No shortness of breath and appearance of it No muscular pain and appearance of it Mortality rate during 28 days after beginning of the disease ICU need during 28 days after beginning the disease

Notes
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 3

Arms
Last imported at : March 18, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 611, "treatment_name": "Hyperimmune milk", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]